Research Study Opportunities
- Cadisegliatin a Adjunctive Therapy in Type 1 Diabetes: A 52 Week Double Blind, Randomized, Placebo Controlled Phase 3 Study (CATT1)
- Eversense® Continuous Glucose Monitor (CGM): A Post-Approval Study to Evaluate the Safety and Effectiveness of the Eversense® CGM System Used Non-Adjunctively (without another meter to compare)
- Peripheral Diabetic Neuropathy: A Phase 2 Study to Evaluate the Safety and Efficiency of RTA901 in Patients with Diabetic Peripheral Neuropathic Pain
- A Phase 2, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of CT-868 Administered for 16 Weeks to Overweight and Obese Adult Participants with Type 1 Diabetes Mellitus
- A Randomized, Double-Blind, Placebo Controlled, Phase 2b Study to Assess the Efficacy, Safety and Tolerability of IMVT-1402 as Treatment for Adult Patients with Graves’ Disease.